Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 442


Molecular Genetics of von Willebrand Disease in Korean Patients: Novel Variants and Limited Diagnostic Utility of Multiplex Ligation-Dependent Probe Amplification Analyses.

Kim HJ, Kim SK, Yoo KY, Lee KO, Yun JW, Kim SH, Kim HJ, Park SK.

Ann Lab Med. 2019 Nov;39(6):545-551. doi: 10.3343/alm.2019.39.6.545.


Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies.

Kim H, Yun JW, Lee ST, Kim HJ, Kim SH, Kim JW; Korean Society for Genetic Diagnostics Clinical Guidelines Committee.

Ann Lab Med. 2019 Nov;39(6):515-523. doi: 10.3343/alm.2019.39.6.515. Review.


Clonal dominance of a donor-derived del(20q) clone after allogeneic hematopoietic stem cell transplantation in an acute myeloid leukemia patient with del(20q).

Yoon J, Yun JW, Jung CW, Kim HJ, Kim SH.

J Clin Lab Anal. 2019 Jun 11:e22951. doi: 10.1002/jcla.22951. [Epub ahead of print]


Flow Cytometric Analysis of T Cells in Hemophagocytic Lymphohistiocytosis.

Park MS, Yoo IY, Kim HJ, Kim SH, Kim SJ, Cho D.

Ann Lab Med. 2019 Sep;39(5):430-437. doi: 10.3343/alm.2019.39.5.430.


Magnetic Resonance Imaging and Bioluminescence Imaging for Evaluating Tumor Burden in Orthotopic Colon Cancer.

Ravoori MK, Margalit O, Singh S, Kim SH, Wei W, Menter DG, DuBois RN, Kundra V.

Sci Rep. 2019 Apr 15;9(1):6100. doi: 10.1038/s41598-019-42230-w.


Nonsteroidal Anti-inflammatory Drugs Sensitize CD44-Overexpressing Cancer Cells to Hsp90 Inhibitor Through Autophagy Activation.

Moon HJ, Park SY, Lee SH, Kang CD, Kim SH.

Oncol Res. 2019 Jul 12;27(7):835-847. doi: 10.3727/096504019X15517850319579. Epub 2019 Apr 8.


Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion.

Yun JW, Bae YK, Cho SY, Koo H, Kim HJ, Nam DH, Kim SH, Chun S, Joo KM, Park WY.

Int J Mol Sci. 2019 Apr 6;20(7). pii: E1717. doi: 10.3390/ijms20071717.


Hereditary platelet function disorder from RASGRP2 gene mutations encoding CalDAG-GEFI identified by whole-exome sequencing in a Korean woman with severe bleeding.

Yun JW, Lee KO, Jung CW, Oh SY, Kim SH, Choi CW, Kim HJ.

Haematologica. 2019 Jun;104(6):e274-e276. doi: 10.3324/haematol.2019.218487. Epub 2019 Mar 7. No abstract available.


Development and validation of self- and caregiver-report of a distress screening tool for pediatric cancer survivors.

Yoon SJ, Chung KM, Han JW, Hahn SM, Kim SH, Lyu CJ.

Support Care Cancer. 2019 Feb 25. doi: 10.1007/s00520-019-04708-1. [Epub ahead of print]


HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia.

Park JH, Woo YM, Youm EM, Hamad N, Won HH, Naka K, Park EJ, Park JH, Kim HJ, Kim SH, Kim HJ, Ahn JS, Sohn SK, Moon JH, Jung CW, Park S, Lipton JH, Kimura S, Kim JW, Kim DDH.

Leukemia. 2019 Jun;33(6):1439-1450. doi: 10.1038/s41375-018-0321-8. Epub 2018 Dec 16.


The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma.

Kim SH, Roszik J, Cho SN, Ogata D, Milton DR, Peng W, Menter DG, Ekmekcioglu S, Grimm EA.

Clin Cancer Res. 2019 Mar 1;25(5):1650-1663. doi: 10.1158/1078-0432.CCR-18-1163. Epub 2018 Dec 11.


Mitochondrial dynamic alterations regulate melanoma cell progression.

Dal Yontem F, Kim SH, Ding Z, Grimm E, Ekmekcioglu S, Akcakaya H.

J Cell Biochem. 2018 Sep 6. doi: 10.1002/jcb.27518. [Epub ahead of print]


Advanced Electron Paramagnetic Resonance Studies of a Ternary Complex of Copper, Amyloid-β, and a Chemical Regulator.

Hong S, Go YK, Derrick JS, Han S, Kim J, Lim MH, Kim SH.

Inorg Chem. 2018 Oct 15;57(20):12665-12670. doi: 10.1021/acs.inorgchem.8b01824. Epub 2018 Sep 21.


First Case of Plasma Cell Myeloma With Brown Tumor Features Unrelated to Hyperparathyroidism.

Kim H, Kim K, Cho SR, Kim HJ, Kim SH.

Ann Lab Med. 2019 Jan;39(1):96-98. doi: 10.3343/alm.2019.39.1.96. No abstract available.


Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3'-overhang.

Bin Moon S, Lee JM, Kang JG, Lee NE, Ha DI, Kim DY, Kim SH, Yoo K, Kim D, Ko JH, Kim YS.

Nat Commun. 2018 Sep 7;9(1):3651. doi: 10.1038/s41467-018-06129-w.


Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in KIT-Mutant Melanoma.

Oba J, Kim SH, Wang WL, Macedo MP, Carapeto F, McKean MA, Van Arnam J, Eterovic AK, Sen S, Kale CR, Yu X, Haymaker CL, Routbort M, Haydu LE, Bernatchez C, Lazar AJ, Grimm EA, Hong DS, Woodman SE.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00055. Epub 2018 Jun 5. No abstract available.


Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia.

Kim HY, Lee KO, Park S, Jang JH, Jung CW, Kim SH, Kim HJ.

Ann Lab Med. 2018 Nov;38(6):495-502. doi: 10.3343/alm.2018.38.6.495.


Data on the respiratory sensor performance prepared with the MWCNT coated textile fabricated by vacuum-filtration.

Ko J, Jee S, Lee JH, Kim SH.

Data Brief. 2018 May 23;19:638-641. doi: 10.1016/j.dib.2018.05.087. eCollection 2018 Aug.


SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4+ T Cells.

Antonucci JM, Kim SH, St Gelais C, Bonifati S, Li TW, Buzovetsky O, Knecht KM, Duchon AA, Xiong Y, Musier-Forsyth K, Wu L.

J Virol. 2018 Jul 17;92(15). pii: e00292-18. doi: 10.1128/JVI.00292-18. Print 2018 Aug 1.


Ethnicity-specific impact of HLA I/II genotypes on the risk of inhibitor development: data from Korean patients with severe hemophilia A.

Kim HY, Cho JH, Kim HJ, Chung HS, Kim SH, Lee KO, Jung SY, Yoo KY, Kim HJ.

Ann Hematol. 2018 Sep;97(9):1695-1700. doi: 10.1007/s00277-018-3358-x. Epub 2018 May 16.


Supplemental Content

Loading ...
Support Center